Cargando…
Utilizing Chemical Genomics to Identify Cytochrome b as a Novel Drug Target for Chagas Disease
Unbiased phenotypic screens enable identification of small molecules that inhibit pathogen growth by unanticipated mechanisms. These small molecules can be used as starting points for drug discovery programs that target such mechanisms. A major challenge of the approach is the identification of the...
Autores principales: | Khare, Shilpi, Roach, Steven L., Barnes, S. Whitney, Hoepfner, Dominic, Walker, John R., Chatterjee, Arnab K., Neitz, R. Jeffrey, Arkin, Michelle R., McNamara, Case W., Ballard, Jaime, Lai, Yin, Fu, Yue, Molteni, Valentina, Yeh, Vince, McKerrow, James H., Glynne, Richard J., Supek, Frantisek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506092/ https://www.ncbi.nlm.nih.gov/pubmed/26186534 http://dx.doi.org/10.1371/journal.ppat.1005058 |
Ejemplares similares
-
Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness
por: Khare, Shilpi, et al.
Publicado: (2016) -
High-Throughput Screening of the ReFRAME Library Identifies Potential Drug Repurposing Candidates for Trypanosoma cruzi
por: Bernatchez, Jean A., et al.
Publicado: (2020) -
Spatial metabolomics identifies localized chemical changes in heart tissue during chronic cardiac Chagas Disease
por: Dean, Danya A., et al.
Publicado: (2021) -
Novel chemical starting points for drug discovery in leishmaniasis and Chagas disease
por: Roquero, Irene, et al.
Publicado: (2019) -
An Integrated Approach to Identify New Anti-Filarial Leads to Treat River Blindness, a Neglected Tropical Disease
por: Tyagi, Rahul, et al.
Publicado: (2021)